Combined Therapy in Age-Related Macular Degeneration (ARMD)
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of combined intravitreal therapy
with or without prior photodynamic therapy in patients with wet age-related macular
degeneration (AMD).
In patients with wet AMD, a significant improvement in vision was observed after combined
intravitreal therapy with or without prior photodynamic therapy. Both the pharmacological
effects of the drugs and the physiological effects of the pars plana vitrectomy (posterior
vitreous detachment, liquefaction, and oxygen redistribution) may have contributed to the
long-term sustainability of the therapeutic benefits.